Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kavia R et al. – These data show that brain responses to bladder filling are abnormal in FS. The explanation for this that best explains the evidence is that the primary abnormality is an overactive urethra that generates abnormally strong inhibitory afferent signals, so effectively blocking bladder afferent activity at the sacral level and deactivating the PAG and higher centres, with consequent loss of bladder sensation and ability to void. Apparently, a normal mechanism for suppression of incontinence involving the striated urethral sphincter becomes exaggerated in FS and prevents voiding. SNM seems to act at the sacral level, by blocking inhibition by urethral afferents.


Today in Bladder...keeping you current

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09

Today in Penis/Urethra...keeping you current

Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
BJU International, 11/17/09

Implant protocol helps reduce penile shortening
Urology Times, 11/06/09

Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study
International Journal of Impotence Research, 11/23/09

Today in Voiding Dys/Incontinence...keeping you current

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09

TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial
International Urogynecology Journal, 11/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address